National Institutes of Health
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing June 18, 2027.
Overview
The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications that propose pre-clinical and early-stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that aim to prevent Alzheimer's disease (AD), slow its…